Solvay Pharmaceuticals B V

USPTO Trademark & Patent Filings

Solvay Pharmaceuticals B V

Trademark applications and grants for Solvay Pharmaceuticals B V. Solvay Pharmaceuticals B V has 22 trademark applications. The latest application filed is for "XAMINE-XR"

Company Profile
    Company Aliases
  • Solvay Pharmaceuticals B.V
  • Solvay Pharmaceuticals B.V.
  • Solvay Pharmaceuticals B.V. -
  • Solvay Pharmaceuticals, B.V. -
  • SOLVAY PHARMACEUTICALS B.V. - Weesp NL

Trademarks Patents
Patent Applications
Patent ApplicationDate
HETEROCYCLIC COMPOUNDS WITH AFFINITY TO MUSCARINIC RECEPTORS
20120095039 - 13/300800 Stoit; Axel ;   et al.
2012-04-19
BIFEPRUNOX MESYLATE MAINTENANCE DOSE COMPOSITIONS AND METHODS FOR USING THE SAME
20110200687 - 13/042570 EIJGENDAAL; Irene ;   et al.
2011-08-18
5-ARYL-4,5-DIHYDRO-(1H)-PYRAZOLINES AS CANNABINOID CB1 RECEPTOR AGONISTS
20110160459 - 13/042620 LANGE; Josephus H.M. ;   et al.
2011-06-30
Oral Solid Solution Formulation of a Poorly Water-Soluble Active Substance
20110086844 - 12/945570 GORISSEN; Henricus R.M.
2011-04-14
BIFEPRUNOX DOSES FOR TREATING SCHIZOPHRENIA
20110070319 - 12/949944 BOURIN; Michel ;   et al.
2011-03-24
Patent Grants & Applications

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed